Search
for

    Sort by

    Research 61–90 of 1000+

    1. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth International journal of reproductive medicine · 2014 · 222 citations
    2. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis BMC Medicine · 2014 · 122 citations
    3. No evidence for the immunocompetence handicap hypothesis in male humans Scientific Reports · 2018 · 87 citations
    4. MENSTRUAL DISORDERS IN ADOLESCENTS Pediatric Clinics of North America · 1999 · 75 citations
    5. Androgenic Effects on Ventricular Repolarization Circulation · 2019 · 64 citations
    6. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome International Journal of Molecular Sciences · 2020 · 58 citations
    7. ACNE Dermatologic Clinics · 1997 · 58 citations
    8. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    9. Idiopathic Hirsutism* Endocrine Reviews · 2000 · 47 citations
    10. A cell-based system for screening hair growth-promoting agents Archives of Dermatological Research · 2009 · 39 citations
    11. What may be the markers of the male equivalent of polycystic ovary syndrome? Physiological Research · 2004 · 39 citations
    12. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    13. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021 · 36 citations
    14. Clinical relevance of testosterone and dihydrotestosterone metabolism in women ˜The œAmerican journal of medicine · 1995 · 31 citations
    15. The Basic Science of Hair Biology Dermatologic Clinics · 2012 · 29 citations
    16. Synaptic Long-Term Potentiation and Depression in the Rat Medial Vestibular Nuclei Depend on Neural Activation of Estrogenic and Androgenic Signals PLoS ONE · 2013 · 25 citations
    17. Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates General and Comparative Endocrinology · 2020 · 21 citations
    18. Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment Primary Care · 2007 · 21 citations
    19. Androgenetic alopecia; drug safety and therapeutic strategies Expert Opinion on Drug Safety · 2018 · 20 citations
    20. Genetic basis of polycystic ovary syndrome Expert Review of Endocrinology & Metabolism · 2010 · 18 citations
    21. Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome Physiological Research · 2019 · 13 citations
    22. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency Endocrine journal · 2019 · 13 citations
    23. Thyroid hormones and androgens differentially regulate gene expression in testes and ovaries of sexually mature Silurana tropicalis General and comparative endocrinology · 2018 · 13 citations
    24. Treatment of insulin resistance with tirzepatide leading to improvement of hair loss JAAD Case Reports · 2024 · 12 citations
    25. 25 years of ERβ: a personal journey Journal of molecular endocrinology · 2021 · 11 citations
    26. Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors Assay and Drug Development Technologies · 2018 · 11 citations
    27. Dermatologic manifestations of endocrine disorders Current Opinion in Pediatrics · 2012 · 11 citations
    28. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients Ginekologia Polska · 2017 · 9 citations
    29. Big head? Bald head! Skull expansion: alternative model for the primary mechanism of AGA Medical Hypotheses · 2008 · 8 citations
    30. Plasma-Polymerised Antibacterial Coating of Ovine Tendon Collagen Type I (OTC) Crosslinked with Genipin (GNP) and Dehydrothermal-Crosslinked (DHT) as a Cutaneous Substitute for Wound Healing Materials · 2023 · 6 citations